80 related articles for article (PubMed ID: 9705603)
1. Intestinal permeability and contractility in murine colitis.
van Meeteren ME; van Bergeijk JD; van Dijk AP; Tak CJ; Meijssen MA; Zijlstra FJ
Mediators Inflamm; 1998; 7(3):163-8. PubMed ID: 9705603
[TBL] [Abstract][Full Text] [Related]
2. Effect of pharmacologically induced smooth muscle activation on permeability in murine colitis.
Zijlstra FJ; van Meeteren ME; Garrelds IM; Meijssen MA
Mediators Inflamm; 2003 Feb; 12(1):21-7. PubMed ID: 12745545
[TBL] [Abstract][Full Text] [Related]
3. Diminished nitroprusside-induced relaxation of inflamed colonic smooth muscle in mice.
van Bergeijk JD; van Westreenen H; Adhien P; Zijlstra FJ
Mediators Inflamm; 1998; 7(4):283-7. PubMed ID: 9792339
[TBL] [Abstract][Full Text] [Related]
4. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation.
Melgar S; Karlsson A; Michaëlsson E
Am J Physiol Gastrointest Liver Physiol; 2005 Jun; 288(6):G1328-38. PubMed ID: 15637179
[TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinase pathways contribute to hypercontractility and increased Ca2+ sensitization in murine experimental colitis.
Ihara E; Beck PL; Chappellaz M; Wong J; Medlicott SA; MacDonald JA
Mol Pharmacol; 2009 May; 75(5):1031-41. PubMed ID: 19190174
[TBL] [Abstract][Full Text] [Related]
6. Dextran sulphate sodium induces acute colitis and alters hepatic function in hamsters.
Karlsson A; Jägervall A; Pettersson M; Andersson AK; Gillberg PG; Melgar S
Int Immunopharmacol; 2008 Jan; 8(1):20-7. PubMed ID: 18068096
[TBL] [Abstract][Full Text] [Related]
7. Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis.
Poritz LS; Garver KI; Green C; Fitzpatrick L; Ruggiero F; Koltun WA
J Surg Res; 2007 Jun; 140(1):12-9. PubMed ID: 17418867
[TBL] [Abstract][Full Text] [Related]
8. Involvement of CPI-17 downregulation in the dysmotility of the colon from dextran sodium sulphate-induced experimental colitis in a mouse model.
Sato K; Ohkura S; Kitahara Y; Ohama T; Hori M; Sato M; Kobayashi S; Sasaki Y; Hayashi T; Nasu T; Ozaki H
Neurogastroenterol Motil; 2007 Jun; 19(6):504-14. PubMed ID: 17564632
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin does not attenuate intestinal injury in dextran sodium sulphate-induced subacute colitis.
van Bergeijk JD; van Meeteren ME; Tak CJ; van Dijk AP; Meijssen MA; Wilson JH; Zijlstra FJ
Mediators Inflamm; 1998; 7(3):169-73. PubMed ID: 9705604
[TBL] [Abstract][Full Text] [Related]
10. Endogenous and exogenous ghrelin enhance the colonic and gastric manifestations of dextran sodium sulphate-induced colitis in mice.
De Smet B; Thijs T; Moechars D; Colsoul B; Polders L; Ver Donck L; Coulie B; Peeters TL; Depoortere I
Neurogastroenterol Motil; 2009 Jan; 21(1):59-70. PubMed ID: 18823291
[TBL] [Abstract][Full Text] [Related]
11. The specific type-4 phosphodiesterase inhibitor mesopram alleviates experimental colitis in mice.
Loher F; Schmall K; Freytag P; Landauer N; Hallwachs R; Bauer C; Siegmund B; Rieder F; Lehr HA; Dauer M; Kapp JF; Endres S; Eigler A
J Pharmacol Exp Ther; 2003 May; 305(2):549-56. PubMed ID: 12606674
[TBL] [Abstract][Full Text] [Related]
12. Aging in the absence of TLR2 is associated with reduced IFN-gamma responses in the large intestine and increased severity of induced colitis.
Albert EJ; Marshall JS
J Leukoc Biol; 2008 Apr; 83(4):833-42. PubMed ID: 18223102
[TBL] [Abstract][Full Text] [Related]
13. The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation.
Loher F; Bauer C; Landauer N; Schmall K; Siegmund B; Lehr HA; Dauer M; Schoenharting M; Endres S; Eigler A
J Pharmacol Exp Ther; 2004 Feb; 308(2):583-90. PubMed ID: 14610233
[TBL] [Abstract][Full Text] [Related]
14. Adenosine kinase inhibitor GP515 improves experimental colitis in mice.
Siegmund B; Rieder F; Albrich S; Wolf K; Bidlingmaier C; Firestein GS; Boyle D; Lehr HA; Loher F; Hartmann G; Endres S; Eigler A
J Pharmacol Exp Ther; 2001 Jan; 296(1):99-105. PubMed ID: 11123368
[TBL] [Abstract][Full Text] [Related]
15. Antioxidants as novel therapy in a murine model of colitis.
Oz HS; Chen TS; McClain CJ; de Villiers WJ
J Nutr Biochem; 2005 May; 16(5):297-304. PubMed ID: 15866230
[TBL] [Abstract][Full Text] [Related]
16. Increased visceral sensitivity to capsaicin after DSS-induced colitis in mice: spinal cord c-Fos expression and behavior.
Eijkelkamp N; Kavelaars A; Elsenbruch S; Schedlowski M; Holtmann G; Heijnen CJ
Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G749-57. PubMed ID: 17656446
[TBL] [Abstract][Full Text] [Related]
17. Acute experimental distal colitis alters colonic transit in rats.
Myers BS; Dempsey DT; Yasar S; Martin JS; Parkman HP; Ryan JP
J Surg Res; 1997 Apr; 69(1):107-12. PubMed ID: 9202655
[TBL] [Abstract][Full Text] [Related]
18. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
19. The protective effect of the vagus nerve in a murine model of chronic relapsing colitis.
Ghia JE; Blennerhassett P; El-Sharkawy RT; Collins SM
Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G711-8. PubMed ID: 17673544
[TBL] [Abstract][Full Text] [Related]
20. In vivo treatment with a nonapeptide thymic hormone, facteur thymique serique (FTS), ameliorates chronic colitis induced by dextran sulphate sodium in mice.
Sun X; Yamada H; Yoshihara K; Awaya A; Yoshikai Y
Int Immunopharmacol; 2007 Jul; 7(7):928-36. PubMed ID: 17499195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]